Connect cuts 11 SAR-listed firmsBusiness | Kevin Xu 9 Sep 2019
The Shanghai Stock Exchange has excluded 11 SAR-listed stocks from the Shanghai-Hong Kong Stock Connect, including Television Broadcasts (0511) and Chinese Estates Holdings (0127).
It added nine stocks to the connect scheme, including China East Education (0667), Jinxin Fertility Group (1951) and Hansoh Pharmaceutical Group (3692), which listed on the Hong Kong main board three months ago.
Three mainland developers, Ronshine China (3301), Midea Real Estate (3990) and China Aoyuan (3883) were also added to the connect scheme.
Shares of mainland drugmaker Hansoh Pharmaceutical Group surged 94.6 percent to HK$27.75 last Friday compared to its initial public offering price of HK$14.26.
The firm has a drug portfolio for central nervous system diseases, oncology, anti-infectives and diabetes, as well as gastrointestinal and cardiovascular therapeutics.
Shares in assisted reproductive services (ARS) provider Jinxin Fertility closed at HK$10.80 last Friday, up 26.4 percent from its IPO price of HK$8.54.
The Sichuan-based firm ranked third in China's ARS market in 2018, in terms of in vitro fertilization treatment cycles conducted and revenue generated from ARS institutions, with a market share of 3.1 percent and 3.9 percent, according to a Frost & Sullivan research report.